Yufeng Li

631 total citations · 1 hit paper
34 papers, 371 citations indexed

About

Yufeng Li is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yufeng Li has authored 34 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Yufeng Li's work include Tuberculosis Research and Epidemiology (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Yufeng Li is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Yufeng Li collaborates with scholars based in China and United States. Yufeng Li's co-authors include Lemin Zheng, Belinda Willard, Enchen Zhou, Fuquan Yang, Xianghai Zhou, Chenguang Niu, Bing Pan, Xu Wang, Jizhao Li and Lingyun Zu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Yufeng Li

31 papers receiving 367 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data

2025 15 citations Ruizi Ni, Yufeng Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yufeng Li China	11	157	74	61	60	50	34	371
Assefa Agegnehu Teshome Ethiopia	8	79 0.5×	46 0.6×	58 1.0×	18 0.3×	14 0.3×	28	316
Xingcheng Xiong China	10	145 0.9×	58 0.8×	77 1.3×	13 0.2×	105 2.1×	11	534
Donata Scribano Italy	11	104 0.7×	19 0.3×	34 0.6×	28 0.5×	51 1.0×	23	344
Jolanta Sawicka-Powierza Poland	9	60 0.4×	54 0.7×	9 0.1×	22 0.4×	14 0.3×	35	243
Yanmin Liu China	11	164 1.0×	23 0.3×	10 0.2×	37 0.6×	138 2.8×	27	344
Wei‐Kung Tseng Taiwan	12	60 0.4×	31 0.4×	77 1.3×	175 2.9×	37 0.7×	41	437
Juergen Wellmann Germany	7	47 0.3×	13 0.2×	13 0.2×	99 1.6×	10 0.2×	8	272
Naoto Minematsu Japan	13	120 0.8×	74 1.0×	7 0.1×	20 0.3×	58 1.2×	35	627
Xiaolan Lu China	13	130 0.8×	25 0.3×	52 0.9×	36 0.6×	67 1.3×	33	469
Soie Chung South Korea	9	113 0.7×	40 0.5×	66 1.1×	35 0.6×	25 0.5×	23	426

Countries citing papers authored by Yufeng Li

Since Specialization

Citations

This map shows the geographic impact of Yufeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Li more than expected).

Fields of papers citing papers by Yufeng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Li. The network helps show where Yufeng Li may publish in the future.

Co-authorship network of co-authors of Yufeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Li. A scholar is included among the top collaborators of Yufeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Li. Yufeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Huanhuan, Li He, Yufeng Li, et al.. (2025). Rhodium clusters encapsulated by MnPOx microporous membrane for efficient hydroformylation of 1-hexene. Applied Catalysis B: Environmental. 381. 125860–125860. 1 indexed citations

Ye, Zhaoyang, Ling Yang, Zhuang Li, et al.. (2025). Development and Validation of Early Alert Model for Diabetes Mellitus–Tuberculosis Comorbidity. Microorganisms. 13(4). 919–919. 1 indexed citations

Zeng, Tianshu, Xia Li, Chao Zheng, et al.. (2025). Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China. Diabetes Obesity and Metabolism. 28(1). 539–550.

Liu, Wenjuan, Maoxing Tang, Zhaoyi Wang, et al.. (2025). Dibutyl phthalate promotes central precocious puberty through primordial follicle activation by downregulating BMP15. Ecotoxicology and Environmental Safety. 300. 118460–118460.

Ye, Zhaoyang, Yufeng Li, Zhuang Li, et al.. (2024). Mendelian susceptibility to mycobacterial disease: a rare genetic disorder that demands attention. 1(1). 1 indexed citations

Li, Haolong, Fan Ping, Zhihong Wang, et al.. (2023). COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study. Frontiers in Endocrinology. 14. 1172089–1172089. 4 indexed citations

Zou, Xiantong, Yingying Luo, Qi Huang, et al.. (2023). Differential effect of interventions in patients with prediabetes stratified by a machine learning‐based diabetes progression prediction model. Diabetes Obesity and Metabolism. 26(1). 97–107. 10 indexed citations

Lei, Guanglin, Hao Yang, Fang Sun, et al.. (2022). Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma. Human Gene Therapy. 33(5-6). 309–317. 4 indexed citations

Luo, Yingying, et al.. (2022). Sex- and body mass index-specific reference intervals for serum leptin: a population based study in China. Nutrition & Metabolism. 19(1). 54–54. 21 indexed citations

10.

Ni, Jiajia, et al.. (2022). A novel CLCN5 frame shift mutation responsible for Dent disease 1: Case report. Frontiers in Pediatrics. 10. 1043502–1043502. 1 indexed citations

11.

Wang, Linjie, Huihua Ding, Chunyan Wang, et al.. (2022). 25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation. Diabetology & Metabolic Syndrome. 14(1). 23–23. 6 indexed citations

12.

Lv, Fang, Xiaoling Cai, Yufeng Li, et al.. (2022). Association Between Indices of Body Composition and Metabolically Unhealthy Phenotype in China: A Cross-Sectional Study. Frontiers in Endocrinology. 13. 891327–891327. 5 indexed citations

13.

Zhang, Xiuying, et al.. (2020). <p>Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 4361–4368. 12 indexed citations

14.

Li, Yufeng, et al.. (2019). Association between serum uric acid and large-nerve fiber dysfunction in type 2 diabetes. Chinese Medical Journal. 132(9). 1015–1022. 12 indexed citations

15.

Huo, Lili, et al.. (2019). Survival of Chinese people with type 2 diabetes and diabetic kidney disease: a cohort of 12 -year follow-up. BMC Public Health. 19(1). 1498–1498. 5 indexed citations

16.

Kilgore, Meredith L., John P. Shelley, Emily B. Levitan, et al.. (2019). Medicaid Expansion and Hospitalization for Ambulatory Care–Sensitive Conditions Among Nonelderly Adults With Diabetes. Journal of Ambulatory Care Management. 42(4). 312–320. 10 indexed citations

17.

Hao, Xiaohua, Yufeng Li, Jianwen Wang, et al.. (2018). Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis. Frontiers in Immunology. 9. 2089–2089. 26 indexed citations

18.

Zhang, Shaogeng, Yufeng Li, Nana Zhao, et al.. (2017). Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma. Oncology Letters. 14(4). 4551–4556. 2 indexed citations

19.

Li, Yufeng, Mingming Zhao, Dan He, et al.. (2016). HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications. Lipids in Health and Disease. 15(1). 76–76. 14 indexed citations

20.

Dasanayake, Ananda P., Yufeng Li, Nok Chhun, Janet Bronstein, & Noel K. Childers. (2007). Challenges Faced by Minority Children in Obtaining Dental Care. Journal of Health Care for the Poor and Underserved. 18(4). 779–789. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact